Akumincorp
Outpatient imaging and radiation therapy for hospitals, health systems and physician groups across the United States
Highlights
- Hiring2 open roles
- New on EvolcAdded 2026-11-05
- Salary transparent2 of 2 open roles list a salary
About Akumincorp
Akumin provides outpatient radiology and oncology services in the United States. Its diagnostic imaging covers MRI, PET/CT, CT, X-ray, nuclear medicine, DEXA and 3D mammography, and it also delivers radiation therapy for cancer treatment. Services are provided through owned or managed outpatient centers, the company's mobile imaging fleet, and Akumin AXIS relocatable clinics.
Its customers are hospitals, health systems and physician groups, which refer patients to its network; the company states it partners with about 800 hospitals. Patients can also self-schedule appointments at its locations. The company describes its partnerships as focused on patient experience, operational excellence, profitability and market development.
Akumin was founded in 2014 and reports 120+ fixed-site outpatient imaging clinics and about 100 drivers supporting its mobile fleet. Its open positions include MRI and PET/CT technologists, mobile medical trailer truck drivers, patient coordinators, and data and integration engineers. In June 2026 it announced Mobile Healthcare Innovations, a joint venture with CGS Premier to build Akumin AXIS relocatable clinics.
Product: Outpatient MRI, PET/CT, CT, X-ray and radiation therapy services, delivered at fixed sites, by mobile units and in Akumin AXIS relocatable clinics.
Jobs at Akumincorp (2)
Akumincorp is hiring for 2 roles based in Berlin and London.
PET-CT Technologist
New on EvolcSalary transparent$64–79 / hourMRI Technologist
New on EvolcSalary transparentfrom $7,500 / month
More health & medtech companies
Alpha Life Sciences
AI document authoring platform for pharma regulatory and medical writing teams at biotech firms and CROsYoung companyNew on EvolcRemote-friendlySalary transparentAtlantis Health
Patient engagement and behaviour change programmes for pharma and healthcare organisations, grounded in behavioural scienceRemote-friendlySalary transparentAtropos Health
Real-world evidence reports and analytics from healthcare data for health systems and cliniciansNew on EvolcRemote-friendlyAvalere Health
Healthcare advisory, medical communications and marketing services for life sciences companies and healthcare organizationsRemote-friendlyBask Health
Telehealth software platform for building direct-to-patient care businesses with e-prescribing, storefronts and pharmacy fulfillmentRemote-friendlyBrooklyn Health
Willis eCOA platform for rater training and endpoint quality monitoring in CNS clinical trialsRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Marketing & advertising
- ActiveCampaignHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Privacy & consent
- OsanoHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.